ArticleJournal of immunology (Baltimore, Md. : 1950)2022
Minimal Information about MHC Multimers (MIAMM).
Randi Vita, Apurva Mody, James A Overton, Soren Buus, Stephen T Haley, Alessandro Sette, Vamsee Mallajosyula, Mark M Davis, Dale L Long, Richard A Willis and 2 more
Abstract read
In one paragraphArticle in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Randi VitaCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA; rvita@lji.org.ORCID 0000-0001-8957-7612 Apurva ModyCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-3519-2896 Soren BuusLaboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-8363-1999 Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0001-7013-2250 Vamsee MallajosyulaInstitute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-0658-3652 Mark M DavisInstitute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0001-6868-657X Dale L LongDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA; and.
Richard A WillisDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA; and.ORCID 0000-0001-6868-657X Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA.
John D AltmanDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA; and.ORCID 0000-0001-9733-2359 Funding
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0MUsing a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5MVirology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0MIMMUNE EPITOPE AND ANALYSIS PROGRAM: Transplantation of organs, tissues and cells 75N93019C00001 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI WILSON, STEPHEN · 2019 to 2025
$23.1MThe effects of immune-age on immune-response and the molecular mechanisms which drive itP01AI153559 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2021 to 2025
$17.8McGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0MTask Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1MServices to support the OBO foundry standardsR24HG010032 · NHGRI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI MUNGALL, CHRISTOPHER J, PETERS, BJOERN · 2017 to 2019
$1.4MNHGRI NIH HHS R24 HG010032NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93019C00001NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS P01 AI153559NIAID NIH HHS P30 AI050409NIAID NIH HHS U19 AI057229NIDA NIH HHS 75N95020D00005NIH HHS P51 OD011132ORFDO NIH HHS 75N99020D00005
6 · The paper itselfAbstract
With the goal of improving the reproducibility and annotatability of MHC multimer reagent data, we present the establishment of a new data standard: Minimal Information about MHC Multimers (https://miamm.lji.org/). Multimers are engineered reagents composed of a ligand and a MHC, which can be represented in a standardized format using ontology terminology. We provide an online Web site to host the details of the standard, as well as a validation tool to assist with the adoption of the standard. We hope that this publication will bring increased awareness of Minimal Information about MHC Multimers and drive acceptance, ultimately improving the quality and documentation of multimer data in the scientific literature.
Indexed as
HLA-A AntigensHumansIndicators and ReagentsInternetMajor Histocompatibility ComplexMultiprotein ComplexesT-LymphocytesHLA-A AntigensIndicators and ReagentsMultiprotein Complexes
Identifiers
PMID35042788
PMCPMC8830768
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390